By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Study: Comparative Data on Pharma Products Lacking from Previous Decade
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > Study: Comparative Data on Pharma Products Lacking from Previous Decade
Business

Study: Comparative Data on Pharma Products Lacking from Previous Decade

MichaelDouglas1
MichaelDouglas1
Share
3 Min Read
SHARE

Comparative effectiveness research — the direct comparison of care interventions to determine which work best for which patients and which pose the greatest benefits and harms — has long been a pet issue for President Obama.[1

Comparative effectiveness research — the direct comparison of care interventions to determine which work best for which patients and which pose the greatest benefits and harms — has long been a pet issue for President Obama.[1] Although the theory has really never been at the forefront of his very much publicized drive for the passage of the PPACA on his terms, it is a crucial foundation for his ultimate vision of quality healthcare delivery as the ultimate method of controlling costs.

Based upon the results of a new trial in JAMA, this vision has been sorely underutilized, even with stimulus funds to expand its availability. Of the almost 200 pharma products approved by the FDA between 2000 and 2010, only 100 had comparative-effectiveness data, researchers found. Whether or not such information was available depended on several factors, including the existence of an alternative treatment and research ethics. Additionally, the availability of comparative-effectiveness data varied based on treatment area, with proportions reaching up to nearly 90 percent for diabetes medications but only 33 percent for hormones and contraceptives.

It’s the overall lack of CER data and underrepresentation of much of that data into many facets of healthcare that will keep providers ignorant of the overall effectiveness with tried and true therapies versus expensive new agents constantly hitting the pharma marketplace. Although comparative FDA data need to be expanded and enriched, it is just the beginning of the long road in giving physicians all of the information — completely free of biases — to make the most medically informed, cost-effective decisions. This study should serve as a point from which CER can be better defined, as well. | LINK

More Read

Live Streams: A New Way to Market Your Healthcare Facility
Risk Adjustments in ObamaCare
4 Physician Referral-Building Mistakes That Spoil Your Reputation
The Future of Medicine: Do Pre-med Students Have a Clue?
What Healthcare Professionals can Learn from Sales People
  1. The American Recovery and Reinvestment Act of 2009 allocated $1.1 billion to boost comparative-effectiveness research efforts.

Related posts:

  1. Obama’s Push for Comparative Effectiveness Models Needs Greater Adoption A major focus of President Obama’s healthcare reform initiatives included…
  2. Report: Pharma Company Covered Up Known Cardiovascular Risks of Drug GSK (then known as SmithKline Beecham) knew in a 1999…
  3. Analysis: Pharma Payouts to Docs Increasingly Irresponsible in the Age of Reform The role of the physician as spokesperson in the name…

 

TAGGED:FDAhealth care business
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

How Setting Boundaries Helps Trauma Survivors Heal
Health
October 30, 2025
how to improve REM sleep
Unlock Better Sleep: How to Improve REM Sleep Naturally
Wellness
October 30, 2025
uv protection in winter
Winter Sun Safety: Why UV Protection Matters Year-Round
Health
October 29, 2025
Nurse Scheduling Software
Evaluating 7 Best Nurse Scheduling Software
Nursing Technology
October 28, 2025

You Might also Like

Worst Mistakes Healthcare Org. Make When Trying to Attract Patients from the Internet
BusinesseHealthFinance

Benign Neglect: Classic Internet Mistake

January 25, 2014
doctors and nurses physician leadership skill listening
Hospital AdministrationMedical Education

Doctors and Nurses: Doctors need to Order Less, Listen More

February 29, 2012

Defending the Quality Adjusted Life Year (QALY)

May 6, 2011
FDA and social media healthcare
BusinesseHealthPolicy & LawSocial Media

What the FDA’s New Social Media Guidance Means for Marketers

July 11, 2014
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?